This post was originally published on this site
Hologic announced earnings per share of $2.17 on revenue of $1.47B. Analysts polled by Investing.com anticipated EPS of $1.32 on revenue of $1.19B.
Hologic shares are up 2% from the beginning of the year, still down 15.11% from its 52 week high of $85.00 set on February 16, 2021. They are outperforming the S&P 500 which is down 3.78% from the start of the year.
Hologic shares gained 3.89% in after-hours trade following the report.
Hologic’s report follows an earnings beat by J&J on January 25, who reported EPS of $2.13 on revenue of $24.8B, compared to forecasts EPS of $2.12 on revenue of $25.28B.
UnitedHealth had beat expectations on January 19 with fourth quarter EPS of $4.48 on revenue of $73.74B, compared to forecast for EPS of $4.3 on revenue of $72.98B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
